Location: Home > Pharma China Web Edition
  • search
  • go
  • Feature Articles
  • 4/16/2026China Deepens Opening of Biotech and Healthcare Sectors to Attract Glo...
  • 4/16/20262026 Biotech Playbook: Hong Kong at the Centre of China’s Globalisati...
  • 4/15/2026China's Pharma Innovators Pursue a Range of Deal Structures to Support...
  • 4/15/2026China Private Biotech Funding Slows in Deal Count but Reaches US$2 Bil...
  • 4/14/2026PhRMA Warns U.S. Drug Pricing Policies Could Accelerate China's Rise i...
  • 4/13/2026How Big Pharma's China Trials Are Escaping Scrutiny (The Wire China)
  • 4/13/2026China Outbound Biopharma Licensing Surges as Global Demand for Innovat...
  • 4/9/2026China Backs Independent Pricing for Innovative Drugs in Landmark State...
  • 4/9/2026China's Innovative Drug Out-Licensing Surge Tops CNY 400B in Q1 as Gl...
  • 4/8/2026Global Drugmakers Brace for Another Tough China Year as Beijing Intens...
  • 4/7/2026Pharma Bets Big on Chinese Drugmakers (The Wire China)
  • 4/7/2026China NMPA Clears 17 Novel Drugs in First Quarter, Highlighting Sustai...
  • 4/3/2026China's $13B Pharma Boom Drives Growth But Faces Hurdles in US and EU ...
  • 4/1/2026Biotech VCs Move Upstream in China as Competition for Innovation Inten...
  • 3/25/2026IQVIA Report Highlights Rising Use and Intensifying Competition in Chi...
  • 3/24/2026Global Pharma Ramps Up China Investment as 15th Five-Year Plan Priorit...
  • 3/17/2026US Reshoring Push Clouds Long-Term Outlook for China's Contract Drugma...
  • 3/17/2026China to Grant Market and Data Exclusivity for Innovative Drugs for th...
  • 3/13/2026China Private Biotech Financing Slows in February but Larger Deals Sig...
  • 3/12/2026China's Labs Race for the Next First-in-Class Breakthrough
  • 3/10/2026China Challenges High-Priced Gene Therapies with Lower-Cost Alternativ...
  • 3/10/2026China Biotech Dealmaking Defies Seasonal Slowdown as February Licensin...
  • 3/10/2026US Weighs Policy Measures to Address China Biotech Competition
  • 3/9/2026China Biotech Financing Rebounds in Early 2026 as RNA Deals and Global...
  • 3/4/2026China Biotech Outlicensing Surges Past US$52 Billion in Early 2026
  • 3/2/20262026 Biotech Playbook: Hong Kong at the Centre of China's Globalisatio...
  • 2/26/2026China's Healthcare Reform Playbook: Boosting Births and Opening the Do...
  • 2/25/2026China Outpaces US and EU in Drug R&D with Faster Trials and Lower Cost...
  • 2/25/2026Global Pharma Giants Rush to License Chinese Weight-Loss Drugs, Eye Ob...
  • 2/25/2026The Patent Term Compensation and Protection Scope in the Compensated P...
  • Page:1/6 Total number of articles:174: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group